Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Accumulated Expenses of $640265.0 in Q1 2026, little changed quarter-over-quarter from $642754.0 in Q4 2025, and up 62.78% on a YoY basis from $393342.0 in Q1 2025.
Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $640265.0 for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 62.78% year-over-year to $640265.0; the TTM figure through Mar 2026 stood at $640265.0 (up 62.78% YoY), while the FY2025 annual figure was $642754.0, up 64.49% from the prior year.
- Accumulated Expenses was $640265.0 for Q1 2026 at Nexalin Technology, roughly flat from $642754.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $642754.0 in Q4 2025 to a low of $124966.0 in Q2 2024.
- Historically, Accumulated Expenses has averaged $425497.2 across 5 years, with a median of $393342.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses sank 79.3% in 2024, then jumped 188.08% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $539822.0 in 2022, then plunged by 51.6% to $261284.0 in 2023, then jumped by 49.55% to $390745.0 in 2024, then jumped by 64.49% to $642754.0 in 2025, then retreated by 0.39% to $640265.0 in 2026.
- The last three Accumulated Expenses figures came in at $640265.0 (Q1 2026), $642754.0 (Q4 2025), and $290031.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Nexalin Technology | 8.72 Mn | 6.01 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 640,265.00 |
| Dec 31, 2025 | 642,754.00 |
| Sep 30, 2025 | 290,031.00 |
| Jun 30, 2025 | 360,004.00 |
| Mar 31, 2025 | 393,342.00 |
| Dec 31, 2024 | 390,745.00 |
| Sep 30, 2024 | 132,847.00 |
| Jun 30, 2024 | 124,966.00 |
| Mar 31, 2024 | 355,713.00 |
| Dec 31, 2023 | 261,284.00 |
| Sep 30, 2023 | 606,891.00 |
| Jun 30, 2023 | 603,633.00 |
| Mar 31, 2023 | 597,660.00 |
| Dec 31, 2022 | 539,822.00 |
| Sep 30, 2022 | 442,501.00 |
| Dec 31, 2021 | 611,795.00 |